FDAnews
www.fdanews.com/articles/138591-fda-eases-trial-requirements-for-drugs-to-treat-alzheimer-8217-s

FDA Eases Trial Requirements for Drugs to Treat Alzheimer’s

July 21, 2011
The FDA is broadening the allowed participant pool and relaxing MRI requirements for Alzheimer’s drug trials in response to recommendations from a stakeholder working group.
Clinical Trials Advisor